FDA approves Roche hemophilia drug Hemlibra

ZURICH (Reuters) - The U.S. Food and Drug Administration on Thursday approved Roche's Hemlibra for hemophilia suffers, a new medicine the Swiss drugmaker is counting on to help it offset eroding sales of its older medicines that have begun going off patent.